A carregar...
Possible therapeutic role of IgE blockade in irritable bowel syndrome
Omalizumab is a humanized monoclonal antibody that binds to the high-affinity type-I IgE Fc receptors on mast cells (MCs) and basophils, inhibiting the IgE immune pathway. Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder, and dysregulation of the immune system l...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116590/ https://ncbi.nlm.nih.gov/pubmed/27920467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i43.9451 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|